維珍妮(02199.HK):2024財年純利約1.43億港元 按年下跌62.6%
格隆匯6月26日丨維珍妮(02199.HK)發佈公吿,受宏觀經濟不明朗、消費氣氛疲弱影響,集團於2024財年錄得收入約港幣70.17億元,按年減少10.9%。毛利減少16.7%至約港幣15.84億元,毛利率下降1.5個百份點至22.6%。集團於2024財年錄得純利約港幣1.43億元,按年下跌62.6%,純利率亦減少2.9個百份點至2.0%。公司擁有人應占每股基本盈利為11.7港仙。
為與股東分享成果,董事會議決建議就2024財年宣派末期股息每股2.2港仙(2023財年:每股1.8港仙),連同中期股息每股3.5港仙,總股息為5.7港仙,以貫徹集團分派財政年度純利不少於30%的股息政策。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.